Iofina plc (IOF) - Net Assets

Latest as of June 2025: GBX50.32 Million GBX ≈ $6.12K USD

Based on the latest financial reports, Iofina plc (IOF) has net assets worth GBX50.32 Million GBX (≈ $6.12K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX70.23 Million ≈ $8.54K USD) and total liabilities (GBX19.91 Million ≈ $2.42K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check IOF asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX50.32 Million
% of Total Assets 71.66%
Annual Growth Rate N/A
5-Year Change 131.38%
10-Year Change 130.36%
Growth Volatility 199.32

Iofina plc - Net Assets Trend (2006–2024)

This chart illustrates how Iofina plc's net assets have evolved over time, based on quarterly financial data. Also explore Iofina plc balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Iofina plc (2006–2024)

The table below shows the annual net assets of Iofina plc from 2006 to 2024. For live valuation and market cap data, see Iofina plc market cap and net worth.

Year Net Assets Change
2024-12-31 GBX47.79 Million
≈ $5.81K
+6.80%
2023-12-31 GBX44.75 Million
≈ $5.44K
+17.85%
2022-12-31 GBX37.97 Million
≈ $4.62K
+26.74%
2021-12-31 GBX29.96 Million
≈ $3.65K
+45.05%
2020-12-31 GBX20.66 Million
≈ $2.51K
+7.42%
2019-12-31 GBX19.23 Million
≈ $2.34K
+223.30%
2018-12-31 GBX5.95 Million
≈ $723.66
-14.62%
2017-12-31 GBX6.97 Million
≈ $847.55
-58.29%
2016-12-31 GBX16.70 Million
≈ $2.03K
-19.49%
2015-12-31 GBX20.75 Million
≈ $2.52K
-11.67%
2014-12-31 GBX23.49 Million
≈ $2.86K
-18.46%
2013-12-31 GBX28.81 Million
≈ $3.50K
-7.81%
2012-12-31 GBX31.25 Million
≈ $3.80K
+21.25%
2011-12-31 GBX25.77 Million
≈ $3.14K
+7.57%
2010-12-31 GBX23.96 Million
≈ $2.91K
-18.86%
2009-12-31 GBX29.53 Million
≈ $3.59K
+24.46%
2008-12-31 GBX23.72 Million
≈ $2.89K
+825.89%
2007-12-31 GBX2.56 Million
≈ $311.75
+4459.30%
2006-12-31 GBX-58.78K
≈ $-7.15
--

Equity Component Analysis

This analysis shows how different components contribute to Iofina plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1210558708.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock GBX3.11 Million 6.50%
Other Comprehensive Income GBX-3.53 Million -7.39%
Other Components GBX60.69 Million 126.98%
Total Equity GBX47.79 Million 100.00%

Iofina plc Competitors by Market Cap

The table below lists competitors of Iofina plc ranked by their market capitalization.

Company Market Cap
HCW Biologics Inc
NASDAQ:HCWB
$972.53K
FKS Food Sejahtera Tbk PT
JK:AISA
$972.99K
Virax Biolabs Group Limited Ordinary Shares
NASDAQ:VRAX
$978.41K
Companhia Tecidos Santanense Ltda
SA:CTSA3
$979.70K
The Pebble Group PLC
LSE:PEBB
$968.25K
The Real Good Food Company, Inc.
NYSE:RGFC
$966.48K
Wynnstay Group Plc
LSE:WYN
$966.28K
Lapidoth-Heletz Limited Partnership
TA:LPHL-L
$966.23K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Iofina plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 44,750,000 to 47,791,000, a change of 3,041,000 (6.8%).
  • Net income of 2,918,000 contributed positively to equity growth.
  • Other comprehensive income increased equity by 44,001.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income GBX2.92 Million +6.11%
Other Comprehensive Income GBX44.00K +0.09%
Other Changes GBX79.00K +0.17%
Total Change GBX- 6.80%

Book Value vs Market Value Analysis

This analysis compares Iofina plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 169.88x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-12-31 GBX0.00 GBX41.50 x
2007-12-31 GBX0.04 GBX41.50 x
2008-12-31 GBX0.28 GBX41.50 x
2009-12-31 GBX0.29 GBX41.50 x
2010-12-31 GBX0.22 GBX41.50 x
2011-12-31 GBX0.23 GBX41.50 x
2012-12-31 GBX0.25 GBX41.50 x
2013-12-31 GBX0.22 GBX41.50 x
2014-12-31 GBX0.18 GBX41.50 x
2015-12-31 GBX0.16 GBX41.50 x
2016-12-31 GBX0.13 GBX41.50 x
2017-12-31 GBX0.05 GBX41.50 x
2018-12-31 GBX0.05 GBX41.50 x
2019-12-31 GBX0.11 GBX41.50 x
2020-12-31 GBX0.11 GBX41.50 x
2021-12-31 GBX0.16 GBX41.50 x
2022-12-31 GBX0.19 GBX41.50 x
2023-12-31 GBX0.23 GBX41.50 x
2024-12-31 GBX0.24 GBX41.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Iofina plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 6.11%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 5.36%
  • • Asset Turnover: 0.85x
  • • Equity Multiplier: 1.33x
  • Recent ROE (6.11%) is above the historical average (-12.59%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 0.00% 0.00% 0.00x 0.00x GBX-358.12K
2007 -30.50% 0.00% 0.00x 1.18x GBX-1.04 Million
2008 4.86% 0.00% 0.00x 1.04x GBX-1.22 Million
2009 -22.88% -123.53% 0.17x 1.12x GBX-9.71 Million
2010 -21.44% -37.56% 0.51x 1.12x GBX-7.53 Million
2011 -10.28% -16.98% 0.55x 1.09x GBX-5.23 Million
2012 -3.62% -6.07% 0.54x 1.10x GBX-4.26 Million
2013 -13.00% -19.78% 0.39x 1.68x GBX-6.62 Million
2014 -28.31% -25.72% 0.55x 1.98x GBX-9.00 Million
2015 -14.34% -14.64% 0.45x 2.16x GBX-5.05 Million
2016 -21.94% -16.29% 0.55x 2.43x GBX-5.33 Million
2017 -139.75% -46.74% 0.57x 5.28x GBX-10.43 Million
2018 -19.22% -4.77% 0.66x 6.07x GBX-1.74 Million
2019 2.87% 1.89% 0.67x 2.27x GBX-1.37 Million
2020 6.19% 4.30% 0.75x 1.93x GBX-787.50K
2021 30.66% 23.53% 0.88x 1.48x GBX6.19 Million
2022 20.71% 18.64% 0.80x 1.39x GBX4.07 Million
2023 14.67% 13.12% 0.83x 1.35x GBX2.09 Million
2024 6.11% 5.36% 0.85x 1.33x GBX-1.86 Million

Industry Comparison

This section compares Iofina plc's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $274,481,346
  • Average return on equity (ROE) among peers: -8.43%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Iofina plc (IOF) GBX50.32 Million 0.00% 0.40x $968.76K
Biome Technologies Plc (BIOM) $22.86 Million 0.61% 0.46x $62.73K
Croda International PLC (CRDA) $141.90 Million 17.12% 0.88x $48.13 Million
Directa Plus PLC (DCTA) $-1.89 Million 0.00% 0.00x $85.76K
Elementis PLC (ELM) $762.40 Million 20.92% 1.52x $10.19 Million
Essentra PLC (ESNT) $270.80 Million 3.91% 0.82x $2.83 Million
Haydale Graphene Industries (HAYD) $6.60 Million -54.51% 0.17x $174.89K
Hardide PLC (HDD) $7.70 Million -14.76% 0.25x $359.60K
Itaconix plc (ITX) $9.17 Million -62.28% 0.09x $176.39K
Johnson Matthey PLC (JMAT) $1.25 Billion 13.13% 1.31x $42.28 Million

About Iofina plc

LSE:IOF UK Specialty Chemicals
Market Cap
$968.76K
GBX7.96 Billion GBX
Market Cap Rank
#30221 Global
#802 in UK
Share Price
GBX41.50
Change (1 day)
+6.41%
52-Week Range
GBX20.50 - GBX41.50
All Time High
GBX41.50
About

Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, specialty intermed… Read more